Velpatasvir
Showing 1 - 25 of 109
Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)
Recruiting
- Hepatitis C, Chronic
- Pregnancy; Infection
- Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
-
Denver, Colorado
- +4 more
Dec 3, 2022
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)
Active, not recruiting
- Liver Transplant
- Hepatitis C
-
Pittsburgh, PennsylvaniaUPMC
Oct 6, 2022
HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],
Completed
- HCV Coinfection
- +2 more
- Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
- Sofosbuvir/Velpatasvir (SOF/VEL)
-
Baltimore, MarylandJohns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022
Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
- Cardiac MRI
-
Washington, District of Columbia
- +1 more
Feb 1, 2023
Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)
Recruiting
- Hepatitis C
- Awaiting Organ Transplant
- Sofosbuvir/velpatasvir
- Monitoring
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 14, 2022
Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)
Recruiting
- Hepatitis C, Chronic
- Sofosbuvir-Velpatasvir Drug Combination
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh, Magee Womens Hospital
Sep 3, 2021
Elimination of Hepatitis C Virus Among Users of Substances
Not yet recruiting
- Hepatitis C in Substance Users
- Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
- (no location specified)
Aug 14, 2022
Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or
Active, not recruiting
- Chronic Hepatitis C
- People Who Inject Drugs
- velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
-
Atlanta, GeorgiaWellstar Atlanta Medical Center
May 31, 2023
Kidney Transplantation, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)
Active, not recruiting
- Kidney Transplantation
- Hepatitis C
-
Pittsburgh, PennsylvaniaUPMC
Oct 27, 2021
Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)
Recruiting
- Hepatitis C
- HCV RNA Point of Care
- +2 more
-
Sydney, New South Wales, AustraliaNUAA NSP
Aug 19, 2022
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)
Completed
- Hepatitis C Virus Infection
-
Seongnam-si, Gyeonggi-D, Korea, Republic of
- +21 more
Sep 29, 2021
Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))
Recruiting
- Hepatitis C
- +2 more
- Sofosbuvir/velpatasvir (Epclusa®)
-
Hazard, KentuckyARH Medical Mall
Sep 25, 2022
Chronic Hepatitis C Trial in Cairo (Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir /
Recruiting
- Chronic Hepatitis C
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
-
Cairo, EgyptFaculty of medicine Helwan University
Jan 3, 2021
Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus
Recruiting
- Hepatitis C Virus Infection
- +3 more
- Vosevi 400/100/100 Oral Tablet
-
Beigang, Taiwan
- +14 more
Oct 25, 2021
Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)
Active, not recruiting
- Hepatocellular Carcinoma
- +3 more
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Jan 14, 2022
HCV Trial in Bonn, 's-Hertogenbosch, Nijmegen (sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed)
Withdrawn
- HCV
- sofosbuvir/velpatasvir tablet
- sofosbuvir/velpatasvir crushed
-
Bonn, Germany
- +2 more
Dec 4, 2020
Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick
Recruiting
- Hepatitis C
- OraQuick HCV Antibody test (OraSure Technologies, Inc)
- +2 more
-
Clayton South, Victoria, Australia
- +5 more
Aug 16, 2022
Hepatitis C, Acute Hepatitis C Trial in Germany (Sofosbuvir and Velpatasvir)
Completed
- Hepatitis C
- Acute Hepatitis C
- Sofosbuvir and Velpatasvir
-
Berlin-Friedrichshain, Germany
- +13 more
Jul 2, 2021
Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)
Completed
- Chronic Hepatitis C
-
Baltimore, MarylandInstitute of Human Virology University of Maryland
Apr 26, 2021
Hepatitis C, Swallowing Disorder Trial in Nijmegen (velpatasvir)
Completed
- Hepatitis C
- Swallowing Disorder
- velpatasvir
-
Nijmegen, Gelderland, NetherlandsRadboud university medical Center
Oct 16, 2020
Hepatitis C, Lung Transplant Trial in Pittsburgh (Epclusa)
Active, not recruiting
- Hepatitis C
- Lung Transplant
-
Pittsburgh, PennsylvaniaUPMC
Oct 4, 2021
Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)
Active, not recruiting
- Chronic Hepatitis C
- Telemedicine
- Velpatasvir/Sofosbuvir
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Aug 24, 2021